Cargando…
Sclerostin regulation: a promising therapy for periodontitis by modulating alveolar bone
Periodontitis is one of the most prevalent epidemics affecting human health and life recently, and exploration of the pathogenesis and treatment of periodontitis has been valued by scholars. In recent years, sclerostin, a new factor on bone resorption and reconstruction caused by inflammation and me...
Autores principales: | Li, Tian-Jiao, Wang, Rui, Li, Qin-Yang, Li, Chun-Yu, Jiang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339364/ https://www.ncbi.nlm.nih.gov/pubmed/32501831 http://dx.doi.org/10.1097/CM9.0000000000000764 |
Ejemplares similares
-
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
por: Yao, Yao, et al.
Publicado: (2020) -
Sclerostin Modulation Holds Promise for Dental Indications
por: Hassan, Mohamed G., et al.
Publicado: (2018) -
Dental and periodontal phenotype in sclerostin knockout mice
por: Kuchler, Ulrike, et al.
Publicado: (2014) -
The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts
por: Pigeaud, Karina E., et al.
Publicado: (2023) -
The roles of osteocytes in alveolar bone destruction in periodontitis
por: Huang, Xiaofei, et al.
Publicado: (2020)